New Results
A Stable Nano-Vaccine for the Targeted Delivery of Tumor-Associated Glycopeptide Antigens
Kevin R. Trabbic, Kristopher A. Kleski, Joseph J Barchi Jr.
doi: https://doi.org/10.1101/2021.04.27.438445
Kevin R. Trabbic
Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702
Kristopher A. Kleski
Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702
Joseph J Barchi Jr.
Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702

Article usage
Posted April 28, 2021.
A Stable Nano-Vaccine for the Targeted Delivery of Tumor-Associated Glycopeptide Antigens
Kevin R. Trabbic, Kristopher A. Kleski, Joseph J Barchi Jr.
bioRxiv 2021.04.27.438445; doi: https://doi.org/10.1101/2021.04.27.438445
Subject Area
Subject Areas
- Biochemistry (10777)
- Bioengineering (8034)
- Bioinformatics (27256)
- Biophysics (13964)
- Cancer Biology (11110)
- Cell Biology (16026)
- Clinical Trials (138)
- Developmental Biology (8772)
- Ecology (13268)
- Epidemiology (2067)
- Evolutionary Biology (17342)
- Genetics (11678)
- Genomics (15904)
- Immunology (11013)
- Microbiology (26044)
- Molecular Biology (10626)
- Neuroscience (56463)
- Paleontology (417)
- Pathology (1729)
- Pharmacology and Toxicology (2999)
- Physiology (4539)
- Plant Biology (9614)
- Synthetic Biology (2683)
- Systems Biology (6968)
- Zoology (1508)